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osting by EAbstract Background: Tuberculosis is a major contributor to disease burden in the developing
countries. It is considered the second fatal disease all over the world and the third most important
public health problem in Egypt. The direct causes of increasing the burden of tuberculosis are the
inconsistent and fragmented health services. The nursing interventions of tuberculosis in commu-
nity settings require a system of recommendations that ensure the consistency of care.
Objective: The present study aimed at providing a valid evidence-based clinical guideline that
assists nurses to intervene consistently to the newly diagnosed patient with pulmonary tuberculosis.
Methods: The intended guideline was developed according to the criteria of the Scottish Intercolle-
giate Guidelines Network (SIGN) and the American Academy of Neurology. This guideline was
developed based on the need for assessments of the intended users (nurses) and the end-point ben-
eﬁciaries (newly diagnosed patients with pulmonary tuberculosis). The development process of the
guideline consisted of seven main steps. The SIGN appraisal tools were used for the critical appraisal
phase of the retrieved studies, and the ‘‘Appraisal of Guidelines for Research & Evaluation
(AGREE) Instrument’’, that was used for appraising the internal validity of the developed guideline.llegiate Guidelines Network;
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156 A.I. Ahmed et al.Results: The developed guideline included thirty recommendations categorized into four main
themes, which are assessment, nursing diagnosis, nursing care plan and implementation of care plan.
The overall assessment of the guideline revealed that two-thirds of academic appraisers strongly rec-
ommended the guideline to be used in practice and most of practitioner nurses and practitioner phy-
sicians recommended the guideline to be in practice.
Conclusion: The development of this guideline was based on the needs of the targeted users (nurses)
and end-point beneﬁciaries (patients). It was strongly recommended by the appraisers to be used in
the outpatients chest clinics. The study recommended that this developed guideline should be dissem-
inated to the policy makers to be approved for application.
ª 2012 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
Tuberculosis (TB) is among the top ten causes of death in the
world. TB is an important public health problem in the East-
ern Mediterranean Region of the World Health Organization.
Every year, the disease kills 136,000 people and affects 630,000
in that region.1
Tuberculosis is a major contributor to the disease burden in
developing countries.2 It is considered the third most impor-
tant public health problem in the Egypt.3 The global plan to
stop tuberculosis recommended the sustainability and accessi-
bility of the standardized short-course chemotherapy for all
cases of tuberculosis.4 The directly observed treatment strategy
(DOTS) is required to ensure treatment adherence and it helps
to reinforce patients’ motivation to continue treatment.5
The main reasons for the increase of the global burden of
TB are the inadequate health services, improper management
practices resulting in poor case detection, misdiagnosis, and
maltreatment. Demographic changes in world population
(increasing changing age structure), and the impact of increas-
ing HIV add to TB burden.6
Treatment failure is a serious problem for tuberculosis con-
trol program in many countries. In Egypt, it accounts for 3–
5% of treatment outcome of new smear positive cases.7 Treat-
ment failure may occur due to poor compliance of the patient,
practitioner errors, and/or irregularity and loss to follow up
the treatment. Bearing in minds that treatment failure may
be due to the fragmentation and inconsistency of the provided
services as well as inadequate provider-patient relations.8,9
Nurses play a crucial role in tuberculosis control program.The
InternationalCouncil ofNursing (ICN)believes thatnurses are in
a position to advocate for strong tuberculosis control programs
and to implement the elements of DOTS.10 Nowadays most
tuberculosis treatment is carried out in the community settings.
Treatment is best supervised by nurses in regular contact with
the patient. Themain principle of nursing intervention is the inte-
grated organization of multiple activities to achieve speciﬁc out-
comes for patients.11 The nursing intervention requires a system
of recommendations that improve performance and support the
quality of health services. This system of recommendations can
be obtained through developing evidence-based clinical practice
guidelines that are deﬁned as ‘‘systematically developed state-
ments to assist practitioner and patient decision about appropri-
ate health care for speciﬁc clinical circumstances’’.12
Clinical practice guidelines are important tools used by
interdisciplinary health care providers to close gaps between
current and optimal practices. In addition, guidelines are used
to specify and standardize the processes of care for speciﬁcpatient populations with deﬁned health related conditions, as
well as, to operate the implementation of evidence-based prac-
tice.13 Guidelines result from a synthesis of available scientiﬁc
knowledge as well as expert consensus. The valid evidence-
based clinical practice guidelines should integrate the expertise
of a multidisciplinary group of clinicians with the perspectives
of consumers and the best available research evidence, to make
recommendations that support clinical decision-making.14
By describing recommended courses of action, guidelines are
intended to assist the decision of the practitioner and patient by
regarding themost appropriate care process for a speciﬁc clinical
condition. When used as an integral component of the quality
improvement process, guidelines are helpful in the identiﬁcation
and analysis of practice variation and the measurable patient’s
outcomes. The periodic review, revision, and distribution of
guidelines help to keep the practitioner’s knowledge base up to
date by dissemination of new advances in everyday practice.15,16
Regarding tuberculosis clinical guideline, it calls for the atten-
tion of the under recognized health problems of tuberculosis pa-
tients and discourages the ineffective interventions to reduce the
morbidity and mortality rates.17 The present study has been
accomplished to provide a valid evidence-based clinical guideline
that assistsnurses to intervene consistently to thenewlydiagnosed
patient with pulmonary tuberculosis at community setting.
2. Material and methods
The intended guideline was developed according to the criteria
of the Scottish Intercollegiate Guidelines Network (SIGN)
2008 and the American Academy of Neurology 2004.18,19
2.1. Process of guideline development
2.1.1. Determination of needs and scope of the guideline
Pulmonary tuberculosis was chosen as a re-emerging disease in
Egypt. Needs and scope of the present Evidence-Based Clinical
Practice Guideline (EBCPG) were identiﬁed through assessing
the current knowledge and performance of the intended users
(nurses) and the end point beneﬁciaries (newly diagnosed pa-
tients with tuberculosis). Nurses and patients were involved
also to fulﬁll the requirement of the evidence-based triad.20
The needs of the assessment were carried out during the
period of four months at the six out-patients’ chest clinics all
over the Dakahlia governorate. Each out-patient’s chest clinic
was visited twice/ month with a total eight visits for each clinic.
Three tools were developed by the researchers and tested for
validity by carrying out a pilot study on ﬁve nurses and ﬁve
patients. Tools were also revised by three community health
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ered all over the development process of the guideline.
2.1.1.1. Assessing knowledge and performance of nurses. All
nurses (n= 28) who are working in the six outpatients’ chest
clinics of Dakahlia governorate during the study, were in-
volved in the study. The distribution of nurses was 15 nurses
at El-Mansoura chest clinic, (four nurses) at El-Manzala chest
clinic, (two nurses) at Belkas, (3 nurses) at Aga, (two nurses)
Dekernes, and (two nurses) at Sherbin.
Knowledge assessment of nurses: A self administered knowl-
edge questionnaire was developed and used to assess nurses’
knowledge regarding the nature of tuberculosis, manifestations,
and the role of nurses inmanaging newly diagnosed patients with
pulmonary tuberculosis. The total score of knowledge was 47,
which covers four items namely: the nature of the tuberculosis,
13 scores (deﬁnition of tuberculosis, causative agent, types of
tuberculosis, modes of transmission, and manifestations), the
treatment strategy 16 scores, (types of treatment, duration, side
effect, and Directly Observed Treatment Strategy), and nursing
role 18 scores. Open ended questions were used to avoid guess-
ing. Self administered questionnaire sheets were distributed to
nurses to assess their knowledge about the management of newly
diagnosed patients with pulmonary tuberculosis.
Assessment of nurses’ performance: Semi-structured inter-
view sheet for the exploration of nurses’ performance included
open ended questions about the actual nursing intervention for
newly diagnosed pulmonary tuberculosis patients. This sheet
includes four main questions about initial patient’s assessment,
health education, follow-up activities, and documentation.
Probing terms were used to obtain answers of the interview
questions. Probing terms included demographic information,
health history, and barriers of patient’s adherence, contacts
investigations, treatment side effect, and notiﬁcation of missed
doses, patient’s satisfaction, and information conﬁdentiality.
An interview was carried out with each nurse for 20–30 min
by obtaining information about their actual performance in
managing newly diagnosed pulmonary tuberculosis patients.
2.1.1.2. Assessing the needs of newly diagnosed patients with
tuberculosis. All newly diagnosed pulmonary patients with
tuberculosis (n= 36) were included in the study. They were
admitted to the mentioned chest clinics during four months. (
Newly diagnosed patient: A patient who has never had treatment
for TB or who has taken anti-tuberculosis drugs for less than
four weeks).21
Semi-structured patients’ expectations interview sheet was
used to identify the expectations of newly diagnosed patients
with pulmonary tuberculosis regarding the role of nurse in the
management of disease. This sheet included two questions about
interpersonal relationship and the function role of nurses in
tuberculosis management. Probing terms such as communica-
tion, assessment, treatment administration, and follow up were
used to obtain answers of the interview questions. Interviews
were carried out with patients throughout the eight visits of each
clinic and each patient was interviewed for 10–15 min.
2.1.1.3. Guideline development group. A peer group of work in-
cludes three members as follows: three community health nurs-
ing specialist, two of them have additional experiences in
epidemiology, environmental health, and evidence-based prac-
tice. The peer group is appropriate for the local use guideline.222.1.1.4. Stating clinical search questions. Fifteen clinical search
questions were constructed by using the PICO (P = patient,
I = intervention, C = comparison, O = outcome) (Box 1). 20
Box 1 Clinical search questions.
(1)What are the assessment methods of newly diagnosed patient
with pulmonary tuberculosis?
(2)What are the risk factors resulting in defaulting in patient with
pulmonary tuberculosis?
(3)How do nurses diagnose health needs and problems in newly
diagnosed patient with pulmonary tuberculosis?
(4)What are the principles of pulmonary tuberculosis treatment?
(5)What are the best measures to prevent pulmonary tuberculosis
among contacts patient with pulmonary tuberculosis?
(6)What are the best measures to control pulmonary tuberculosis?
(7)What is the role of nurse in managing the newly diagnosed
pulmonary tuberculosis?
(8)What are the components of educational program for patient
with pulmonary tuberculosis and contacts?
(9)Does follow-up of newly diagnosed patient with pulmonary
tuberculosis increase the adherence of treatment?
(10)What are the nutritional requirements of patient with
pulmonary tuberculosis?
(11)What is the nursing role in implementing the DOTS strategy?
(12)How to increase the adherence of newly diagnosed patient with
pulmonary tuberculosis to treatment?
(13)What are the types of nursing records that are used in chest out
patients’ clinics?
(14)What are the infection control measures to be followed to
prevent spreading of tuberculosis infection?
(15)What is the ethical aspect of pulmonary tuberculosis
management?2.1.1.5. Searching for the evidence.A literature searchwas under-
taken to identify potentially relevant evidence to develop the in-
tended evidence-based guideline. The guideline development
group reviewed a set of primary and secondary researches and
evidence-based guidelines for tuberculosismanagement.Review
of the literature was conducted from electronic bibliographic
database. The review of literatures was conducted from 1990 up
to 2008 and only English language was utilized during the search.
The searched bibliographic database is illustrated in Box 2.
Box 2 Searched bibliographic database.
http://www.pubmed.gov http://ovidsp.tx.ovid.com
Science direct: http://
www.sciencedirect.com
Center for Review and
Dissemination (CRD) at:
www.york.ac.uk/ins/crd/
Wily Blackwell: http://
onlinelibrary.wiley.com/
http://search.ebscohost.com/
WHO: www.who.net CDC: www.cdc.gov
Scottish Intercollegiate
Guidelines Network at:
http://www.sign.ac.uk/
Cochrane Library, Database of
Systematic Reviews: http://
www.3.interscience.wiley.com/
cgi-bin/mrwhome/106568753/Hom
National Institute for
Health and Clinical
Excellence (NICE) at:
www.nice.org.uk
National Electronic Library for
Health at: www.libararyies.nelh.nhs.uk/
guidelinesﬁnder/
National Guideline
Clearinghouse at:
www.guideline.gov
A.I. Ahmed et al.The search terms that were used for answering the clinical
questions are: ‘‘Nursing role in tuberculosis management’’
 ‘‘Assessment of patient with pulmonary tuberculosis ‘‘
 ‘‘DOTS strategy’’
 ‘‘Adherence and compliance to pulmonary tuberculosis treatment’’
 ‘‘Diagnoses of tuberculosis’’
 ‘‘Health education and pulmonary tuberculosis’’
The numbers of obtained documents were 324 studies, the
multi-drug resistance and treatment failure studies were ex-
cluded. These documents included systematic reviews of ran-
domized trials, cohort studies, cross sectional, case-control
studies, expert opinion and guidelines management for newly
diagnosed patient with pulmonary tuberculosis. Actually valid
and used references were 59 references.
2.1.1.6. Evaluation of evidence and grading recommendations. The
retrieved studies were appraised by two members of the develop-
ment group according to the SIGN system.18 The SIGN system in-
cluded three main steps to evaluate evidence and grade the
guideline recommendations,namely; studyvalidity rating,determi-
nation level of evidence and ﬁnally the grade of recommendation.
First step: study validity rating
All primary studies and reviews addressing the relevant to-
pic were appraised by using SIGN checklist that was appropri-
ate to the study design, and then were individually rated for
internal validity using the system that is shown in Box 3. 18
Box 3 Rating of the internal validity description system for
studies according to the Scottish Intercollegiate Guideline Net-
work (SIGN) System.
Rating Description
++ All or most of the criteria have been fulﬁlled
+ Some of the criteria have been fulﬁlled
 Few or no criteria fulﬁlled
158Second step: determination level of evidence:
The study design is assigned by numerical preﬁx using the
system below (Box 4):
Box 4 Numerical preﬁx assigned to different study designs
according to the Scottish Intercollegiate Guideline Network
(SIGN) System.
Numerical preﬁx Study designs
1 For systematic review or meta analysis or
randomized control trials (RCTs)
2 For cohort and case control studies
3 For case report series
4 For expert opinion/logical argument/common
senseThen each study is assigned to a level of evidence by using
the system below (Box 5):
Box 5 The level of evidence system according to the Scottish
Intercollegiate Guideline Network (SIGN) System.Level of evidence Type of Evidence
1++ High quality meta analysis systematic reviews of
randomized control trials with a very low risk of
bias
1+ Well conducted meta-analysis systematic reviews
or randomized control trials with a low risk of
bias
1 Meta-analysis, systematic reviews, or randomized
control trials with a high risk of bias
2++ High quality systemic reviewers of case-control
or cohort studies with a very low risk of bias and
a high probability that the relationship is causal
2+ Well conducted case-control or cohort studies
with a low risk of bias and a moderate
probability that the relationship is causal
2 Case-control or cohort studies with a high risk
of bias and a signiﬁcant risk that the relationship
is not causal
3 Non-analytic studies, e.g., case reports, case
series
4 Expert opinionThird step: grade of recommendation
The detailed results of each study were considered in the
formulation of each guideline recommendation which was then
graded using the following system (Box 6)
Box 6 Grading system of the guideline recommendations
according to the Scottish Intercollegiate Guideline Network
(SIGN) System.
Grade Recommendation
A At least one meta-analysis, systematic review,
or RCT rated as 1++. And directly applicable
to the target population, or a body of evidence
consisting principally of studies rated as 1+,
directly applicable to the target population and
demonstrating overall consistency of results
B A body of evidence including studies rated as
2++, directly applicable to the target population
and demonstrating overall consistency of result,
or extrapolated evidence from studies rated as
1++ or 1+
C A body of evidence including studies rated as 2+,
directly applicable to the target population and
demonstrating overall consistency of result, or
extrapolated evidence from studies rated as 2++
D Evidence level 3 or 4, or extrapolated evidence from
studies rated as 2+2.1.1.7. Formulation of guideline drafts. A draft of the intended
guideline including pathway of tuberculosis patient in outpa-
tients’ chest clinics algorithm was drawn up. The results of
the needs of the assessment of the intended users of the guide-
line (nurses) and end-point beneﬁciaries (newly diagnosed pa-
tient with pulmonary tuberculosis) were considered during
stating the guideline recommendation statements. The guide-
line development group met 16 times over a period of seven
month. The guideline was redrafted three times before the ﬁnal
approved format.
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The developed guideline was revised by the ‘‘Appraisal of
Guidelines for Research & Evaluation (AGREE) Instru-
ment’’.23 The ‘‘AGREE Instrument’’ was adopted and used
by the guideline developers to follow a structured and rigorous
development methodology and as a self assessment tool to en-
sure that the guideline is sound.
According to the ‘‘AGREE Instrument’’ the number of
appraisers to be ranged from 2 to 4 appraisers to ensure the ap-
praisal reliability of the guideline. However; the appraisers
group of this guideline, involved academic nursing staff mem-
bers (n= 3) and academic medical staff members (n= 3). The
academic staff members were specialists in one or more ﬁelds
of community health, epidemiology, microbiology, and chest
diseases. As well as practitioner nurses (n= 6) and practi-
tioner physicians (n= 7) who are working in out-patient chest
clinics were included as appraisers.
The ‘‘AGREE Instrument’’ consists of 23 key items orga-
nized in six domains. Each domain is intended to capture a
separate dimension of the guideline quality as the following:
 Scope and purpose include three items that are concerned with the
overall aim of the guideline, the speciﬁc clinical questions, and the
target patient population.
 Stakeholder involvement includes four items that focus on the
extent to which the guideline represents the views of its intended
users.
 Rigor of development includes seven items related to the process
used to gather and synthesize the evidence and methods to formu-
late the recommendations and to update them.
 Clarity and presentation include four items dealing with the lan-
guage and format of the guideline.
 Applicability includes three items pertain to the likely organiza-
tional, behavioral and cost implications of applying the guideline.
 Editorial independence includes two items that are concerned with
the independence of the recommendations and acknowledgment of
possible conﬂict of interest from the guideline development group.
Each item is rated on a 4-point scale ranging from 4
‘strongly agree’ to 1 ‘strongly disagree’, with two mid points:
3 ‘agree’ and 2 ‘disagree’. The scale measures the extent to
which an item has been fulﬁlled. A section for overall assess-
ment is included at the end of the instrument. This contains
a series of options ‘strongly recommend’, ‘recommend (with
provisos or alterations)’, ‘would not recommend’ and ‘unsure’.Table 1 Calculation of the minimum and maximum possible dom
Instrument’’.
Domains Scores Academic nursi
staﬀ (n= 3)
Scope and Purpose (three items) Maximum 36
Minimum 9
Stakeholder involvement (four items) Maximum 48
Minimum 12
Rigor of development (seven items) Maximum 84
Minimum 21
Clarity and presentation (four items) Maximum 48
Minimum 12
Applicability (three items) Maximum 36
Minimum 9
Editorial independence (two items) Maximum 24
Minimum 6The overall assessment requires the appraiser to make a judg-
ment as to the quality of the guideline, taking each of the ap-
praisal criteria into account.
Calculating domain scores:
Domain scores can be calculated by the following formulas:
Maximum possible score
¼ 4 ðstrongly agreeÞ  ðnumber of domain’s itemsÞ
 ðnumber of appraisersÞ
Minimum possible score
¼ 1 ðstrongly disagreeÞ  ðnumber of domain’s itemsÞ
 ðnumber of appraisersÞ
The minimum and maximum possible dominos scores of the
present guideline were calculated as in the following (Table 1):
Domain scores can be calculated by summing up all the
scores of the individual items in a domain and by standardiz-
ing the total as a percentage of the maximum possible score for
that domain.
½Obtained scoreminimum possible score
Maximum possible scoreminimum possible score
 100:
A Pilot study was conducted on ﬁve patients and three nurses
to test the validity and clarity of the developed tools number 1,
2 and 3. The developed tools were amended according to the
pilot’s study results.
2.2. Ethical considerations
– Communication and ofﬁcial approval were obtained from the
directorates of each outpatient chest clinic.
– Informed written consents were obtained from nurses and patients
to participate in the study.
– The obtained information is considered conﬁdential and kept in
closed cabinet for 5 years and accessed only by the research team.
2.3. Statistical analysis
Simple frequency tables and arithmetic means were calculated
by SPSS package version 9.00 to illustrate the obtained data.inos scores of the present guideline according to the ‘‘AGREE
ng Academic medical
staﬀ (n= 3)
Practitioner
nurses (n= 6)
Practitioner
physicians (n= 7)
36 72 84
9 18 21
48 96 112
12 24 28
84 186 196
21 42 49
48 96 112
12 24 28
36 72 84
9 18 21
24 48 56
6 12 14
160 A.I. Ahmed et al.3. Results
Results consisted of three parts; ﬁrstly, the results of the needs
assessment. Secondly, the guideline’s content and recommen-
dations’ grading, and ﬁnally the guideline revision and evalua-
tion of internal validation.
3.1. Part 1: Needs assessment of the intended users and end point
beneﬁciaries
Table 2 shows that nurses have a good level of knowledge
regarding the nature of pulmonary tuberculosis. The etiology,
risk factors, and mode of transmission showed mean score of
4.2 ± 1.3. Their level of knowledge about the manifestations
and treatment regimen of pulmonary tuberculosis was fair with
mean score of 3.7 ± 0.9. On the other hand, their level of
knowledge about treatment side effect and nursing role was
poor with mean score of 2.6 ± 0.8 and 1.02 ± 0.8, respectively.
Regarding the self reported performance of nurses, Table 3
reveals that nurses perform in different manners throughout
the treatment course of pulmonary tuberculosis, according to
their personal competence and capabilities. Nurses reported
that they do not perform most tasks of nursing role. Most of
the nurses were obtaining demographic information, while 17
nurses (60.7%), were assessing the contact. However; follow-
up of patients was done by 14 nurses (50.7%) either by obtain-
ing sputum specimen for bacteriology or by observing the
change in urine color. Only six nurses (21%) were providing
health education about TB and notiﬁed the social workers if
patients missed the appointments of medication. All nurses
recommended that they need a guide to follow in providing
nursing intervention to pulmonary tuberculosis patient. TheyTable 3 Distribution of nurses according to the identiﬁed tasks perfo
out-patient chest clinics.
Task
Obtain demographic information
Obtain vital signs and baseline weight
Obtain past and present health history
Identify the patients’ knowledge and perception about TB
Identify barriers to adherence in taking TB medication
Assess the contact for tubercles infection
Monitoring and follow up by bacteriology test or change in urine color
Observe for side eﬀects or medication reactions
Providing education about TB to health care providers
Notiﬁcation system if pt missed appointments of medication
Assess patient satisfaction with the services or care
Monitor the patient medical records
Assure patient conﬁdentiality
Table 2 Knowledge’s scores of nurses regarding tuberculosis and n
Items Total sco
Nature of the disease 6.00
Manifestations 7.00
Treatment regimen 4.00
Treatment side eﬀect 12.00
Nursing role in managing of tuberculosis patient 18.00mentioned also that there was no nursing contribution in the
plan of tuberculosis management and there were no nursing
guidelines or protocols available in the clinical settings.
Table 4 presents the expectations of newly diagnosed pa-
tients with pulmonary tuberculosis about nursing intervention.
Patients recommended that the role of nurses must be unique
and clear. Half of the interviewed patients mentioned the
necessity for accurate time of receiving medication, followed
by 44.4% who expect nurses to be a link between patient
and physician. While, 33.3% of patients expected continuous
follow-up from nurses and 22% expressed their needs for a
respectful communication manner.
3.2. Part 2: guideline content and recommendations’ grading
3.2.1. Assessment
On the basis of experts opinions’ evidence (graded level 4)3 and
seven researches (graded level 2++),24–30 it was concluded
that social and environmental factors are considered to be risk
factors of tuberculosis infection, as well as lifestyle parameters
(smoking, hygiene and nutritional habits) (Recommendation
number 1.1.1 Box 7). Furthermore, these evidences and other
two level 4 guidelines31,32 emphasized the importance of assess-
ing these risk factors.
On the basis of one cohort study (graded level 2++)30 and
seven guidelines (graded level 4),5,10,31–35 the importance of
providing a base line data about the manifestation, vital signs,
anthropometric measurements, and co-morbid conditions are
recommended (Recommendation number 1.1.2 Box 7)
On the basis of four case control studies (graded level
2++)27,36–38 and one standard of care,32 in addition to one
guideline (graded level 4),35 they emphasized that knowledgermed them in managing newly diagnosed tuberculosis patients at
Number 28 %
28.00 100.00
0.00 0.00
00.00 00.00
00.00 0.00
00.00 0.00
17.00 60.70
14.00 50.7
0.00 00.00
06.00 21.00
06.00 21.00
0.00 00.00
0.00 00.00
0.00 00.00
ursing role.
res Nurses’ scores Level of knowledge
4.2 ± 1.3 Good >65%
3.7 ± 0.9 Fair (50–<65%)
2.5 ± 1.1 Fair (50–<65%)
2.6 ± 0.8 Poor (<50%)
1.02 ± 0.8 Poor (<50%)
Validation of evidence-based clinical practice guideline 161and believes of the patient regarding tuberculosis affect his com-
pliance to treatment (Recommendation number 1.1.3 Box 7).
On the basis of one cohort study (graded level) 2++39 and
two guidelines (graded level 4),31,33 nurse should monitor and
follow up the conduction of diagnostic measures namely; chest
X-ray, tuberculin skin test, and three sputum specimens test
(Recommendation number 1.1.4 Box 7).
On the basis of one expert opinion3 and four guidelines
(graded level 4),31,32,35,40 the contacts should be assessed for
tuberculosis infection within maximum of 15 days (Recom-
mendation number 1.2.1 Box 7).
3.2.2. Nursing diagnosis
On the basis of two guidelines (graded level 4),10,34 the recog-
nition of health needs and problems of patients is an important
base for nursing interventions. Furthermore, clear understand-
ing of patients’ situation is a key for objective intervention
(Recommendation number 2.1 Box 7).
On the basis of three guidelines (graded level 4),34,35,40 it is
recommended that contact assessment must be an evidence of
active case ﬁnding (Recommendation number 2.2 Box 3).
3.2.3. Nursing care plan
On the basis of three guidelines (graded level 4)10,32,34 deﬁning
treatment goals and expected outcomes at the beginning of
treatment, reduce confusion and misunderstanding. The plan
must be realistic and achievable during all stages of treatment
(Recommendations number 3.1–3.8 Box 7).
3.2.4. Implementation of care plan
3.2.4.1. Treatment. Based on two systematic reviews (graded
level 2++),41,42 WHO guideline4 and the National Tuberculo-
sis Program (graded level 4),34 promoting compliance should
be through facilitating treatment access, choosing the most
convenient time, place for direct observation treatment andTable 4 Distribution of newly diagnosed tuberculosis patients
(n= 36) according to their expectations about nursing
intervention.
Items Number %
Accurate timing of medication 18 50
Nurse as link between patient and physician 16 44.4
Continuous follow-up 12 33.3
Proper communication 8 22
Table 5 Appraisal scores (%) of the guideline according to ‘‘Scottish
different appraisers.
Agree instrument items Scores% of domains
Academic nurses Academic physicians
Scope and purpose 77.7 62.9
Stakeholder involvement 66.6 77.7
Rigor of development 76.2 70.1
Clarity and presentation 50.0 66.6
Applicability 67.3 65.3
Editorial independence 90.0 88.0providing other social and medical services (Recommendations
number 4.1.1–4.1.4 Box 7).
3.2.4.2. Health education. According to one cohort study
(graded level 2++) and three guidelines (graded level
4),5,10,35 which revealed that health education is an important
part of effective control program that has a good cure rate of
tuberculosis. The health education should include patient, con-
tacts and care providers. It must address all aspects of disease,
treatment regimen, and side effect of medication, healthy
behavior, and social relationship. Health education targeted
the correction of patient’s perception (Recommendations num-
ber 4.2.1–4.2.3 Box 7).
3.2.4.3. Follow-up and referral. On the basis of one cross sec-
tional studies,28 two cohort studies27,39 (graded level 2++),
and ﬁve guidelines (graded level 4),10,31–33,35 they recom-
mended that patient should be followed-up monthly for treat-
ment adherence, medication side effect, and condition progress
through sputum test. Also, a cohort study (graded level
2++)26 revealed that uncontrolled blood sugar interferes
the effect of anti-tuberculosis medication (Recommendations
number 4.3.1 and 4.3.2 Box 7).
On the basis of two guidelines (graded level4)34,42 and two
systematic reviews (graded level ++2)43,44 if the patient got
disappointed in one visit, the health care worker should con-
duct a home visit to him for ensuring treatment continuity
(Recommendations number 4.3.3 and 4.3.4 Box 7).
3.2.4.4. Documentation and reporting. On the basis of two
guidelines (graded level 4)32,34 which concluded that all pa-
tient information regarding progress, intervention, visit sche-
dule, and obstacles should be recorded accurately and
clearly in special formats and reported to the assigned health
care providers. In addition to one systematic review (graded
level 4),45 emphasized the conﬁdentiality of patient’s infor-
mation as important issue (Recommendations number
4.4.1–4.4.4 Box 7).
3.3. Part 3: guidelines revision and evaluation of internal
validation
Tables 4 and 5 present the results of guidelines revision and eval-
uation of its internal validation according to domains’ scores of
the ‘‘Appraisal of Guidelines for Research & Evaluation
(AGREE) Instrument’’.23 The over all scores of the ﬁrst three do-
mains (scope and purpose, stackholder involvement, and rigor ofIntercollegiate Guidelines Network (SIGN) System ‘‘domains by
Overall score%
Practitioner nurses Practitioner physicians
72.2 73.0 71.5
69.4 53.5 66.8
73.0 66.6 71.5
76.4 66.6 64.4
68.5 61.9 65.8
93.0 91.0 90.5
Table 6 Distribution of appraisers according to their overall assessment of the guideline.
Appraisers Items
Strongly recommended for use in practice Recommended for use in practice
Frequency % Frequency %
Academic nursing staﬀ number = 3 2 66.6 1 33.3
Academic medical staﬀ number = 3 2 66.6 1 33.3
Practitioner nurses number = 6 5 83.3 1 16.6
Practitioner physicians number = 7 5 71.4 2 28.5
Total number of appraisers = 19 14 73.6 5 26.3
162 A.I. Ahmed et al.development) were (71.5%, 66.8% and 71.5%), respectively,
while the score% for the clarity and presentation domain was
64.4%, the applicability domain’s score%was 65.8%and the edi-
torial independence’s score% was 90.5% Table 5.Box 7 Evidence linked recommendations.
Serial Recommendation statements
1 Assessment
1.1 Assessing patient health condition
1.1.1 Obtain essential information about patient’s socio-demographic
1.1.2 Assess the present and past health history
1.1.3 Obtain information about patient’s knowledge and perception ab
1.1.4 Ensures that patient complete the required diagnostic measures
1.2 Assessing patient’s contacts health condition
1.2.1 Assess the patient’s contacts health condition
2 Nursing diagnosis
2.1 Identify the patient’s health needs and problems
2.2 Identify the contacts’ health needs and problems
3 Nursing care plan
3.1 Plan to coordinate the ongoing care and services of clinical visits
3.2 Plan to treatment regimen and visit schedule
3.3 Plan for identiﬁcation of treatment obstacles
3.4 Plan for patient’s motivation to increase adherence to anti-TB m
3.5 Plan for patient’s health education
3.6 Plan for health education of contacts
3.7 Plan to coordinate the ongoing care and services of referral and
3.8 Plan for monitoring and evaluation of patient’s progress
4 Implementation of care plan
4.1 Treatment
4.1.1 Implement the schedule of the prescribed treatment
4.1.2 Conduct daily visit at the ﬁrst two months for observed treatmen
4.1.3 Conduct weekly visit during the complementary four months to
dose for the rest of the week
4.1.4 The nurse should provide motivation and incentives to increase
4.2 Health education
4.2.1 Implement health educational program for patient
4.2.2 Implement health educational program for care provider
4.2.3 Implement health educational program for contacts
4.3 Follow up and referral
4.3.1 Monitor the patient health condition monthly
4.3.2 Check blood sugar level for patient with co-morbid disease diab
4.3.3 Report the social workers about the patient who dropped out an
4.3.4 Ensure that social workers conduct a home visit for the dropped
4.4 Documentation and reporting
4.4.1 Ensure that all patients’ data is complete
4.4.2 Recording data of each visit and all procedures performed to the
4.4.3 Communicating the patient condition with other relevant health
4.4.4 Information of patients and contacts should be considered conﬁdAs regards to the overall assessment of the guideline, two-
thirds of academic nursing and medical staff strongly recom-
mended the guideline to be used in practice and the majority
of practitioner nurses as well as three quadrants of practitionerGrading
data, surrounding environment and lifestyle C
C
out tuberculosis C
B
D
D
D
for specimen collection D
D
D
edication D
D
D
follow up D
D
B
t D
receive a day observed dose and take the D
the treatment compliance D
D
D
D
B
etes mellitus C
appointment of treatment or follow up D
out patient or conduct it by herself (according to policy) C
D
patient by using the appropriate format D
care providers D
ential information C
Validation of evidence-based clinical practice guideline 163physicians recommended the guideline be used in practice
(Table 6).4. Discussion
To accomplish the development of the intended evidence-
based clinical guideline, it was important to explore nurses’
knowledge and practice in relation: to the management of
pulmonary tuberculosis. It was also mandatory to deﬁne
the views of patients regarding nursing role in their
management.46
The nurses’ level of knowledge and their performance and
competence are very important issues to the success of tubercu-
losis treatment. The nurses’ performance affects the patient’s
adherence to tuberculosis treatment regimen.47
The present study revealed a lack of knowledge among
nurses regarding the management of pulmonary tuberculosis.
Furthermore, most of those nurses did not perform several
tasks that are considered the core of nursing role in manag-
ing pulmonary tuberculosis. Several studies are in agreement
with the present study, as they reported a lack of knowledge
regarding the management of pulmonary tuberculosis.48–50
The involvement of clinical practitioner stakeholders and
targeted patients in developing evidence-based guideline en-
hances their acceptance and application of the guideline’s
recommendations.51,52 However; the evidence-based guide-
lines must consider patients’ expectations from the health
care system and their preferences regarding the provided
interventions.53
The present study revealed that patients’ expectations for
nursing interventions in relation to pulmonary tuberculosis in-
cluded continuing of care and follow up, adjusting the medica-
tion time, as well as linking the contacts with physician. These
ﬁndings were conﬁrmed by several studies that indicate that
patients perceived nursing interventions to facilitate contacting
with doctors, follow-up the rest of the treatment, and adjusting
medication time.54–56
There are many guidelines and standards
which5,10,24,31,32,35,40 provided strong foundation for the pres-
ent work, but not all of them have an explicit outline on
how evidence was identiﬁed, interpreted or integrated into
the recommendations. The tuberculosis treatment guideline
in 2003 published by the Centers for Disease Control and Pre-
vention (CDC) developed its recommendations according to
the ‘‘Infectious Diseases Society of America Public Health Ser-
vice Rating System’’. This guideline was compared with guide-
lines for other groups and it was reviewed by external and
internal peer reviewers. CDC guideline 2003 strongly recom-
mended that patient-centered care can be the initial manage-
ment strategy. This strategy should always include an
adherence plan that emphasizes directly observed therapy
(DOT).4 Each patient’s management plan should be individu-
alized to incorporate measures that facilitate adherence to the
drug regimen. Such measures may include social services sup-
port, and coordination of tuberculosis services with those of
other providers, this is in agreement with the present guide-
line’s recommendations.
The investigation of contacts of persons with infectious
tuberculosis guideline published in 2005 by CDC, also pro-
vided supportive foundation to the existing recommendations.However, this document did not provide sufﬁcient methodol-
ogy describing how the guideline was developed, especially
for the searches of electronic database and rating scheme for
the strength of evidence, while the working group was well de-
ﬁned. Although the guideline of CDC 2005 mentioned that
nurses are one of their intended users, it did not directly men-
tion what they should do, while the present guideline identiﬁed
the role of nurse clearly and directly.40
Other guidelines, namely: WHO 2003, ICN 2004, Federal
Bureau of Prisons 2004, NTP 2005, and Tuberculosis Coali-
tion for Technical Assistance 2006, strongly support the rec-
ommendations of the present guideline, but none of them
stated clear, direct, or applicable statements for nursing
interventions.5,10,31,32,34
The present guideline demonstrates several strength points.
Firstly, it elicits patients’ perspectives and considered the ac-
tual nursing performance and their level of knowledge during
the guideline development process. Secondly, the guideline was
evaluated by the intended users (nurses) and their work part-
ners (physicians) who are working in outpatients’ chest clinics.
Most of them mentioned that the guideline is effective, recom-
mendation stated it clearly, and could be easily implemented
by nurses and they are in need for such guideline. Finally,
the guideline is attached with supportive tools which will facil-
itate the nursing interventions. In addition, the guideline for-
mulated within the scope of the WHO guideline for National
Program, which will increase its applicability process in the
future.40
The present guideline is based on different types of studies,
which are cohort studies, systematic review, case-control, cross
sectional studies, and clinical guidelines. The development of
this guideline followed certain process and criteria of guideline
development.14,57–59 All of these references almost have the
same criteria and process for a successful guideline develop-
ment which include proper selection of guideline topic, form
of multidisciplinary group of work, developing clinical ques-
tions, comprehensively review of literature, rating of articles,
and summarizing ﬁnding. Moreover, the successful guideline
should include writting supported practice recommendations,
reviewed and critically appraised by a group of expert review-
ers and intended users by using a standardized tool. Finally,
the guideline should be distributed to practitioners of its ﬁeld
specialty. Also, this guideline met the appraisal criteria of the
‘‘Appraisal of Guidelines for Research & Evaluation
(AGREE) Instrument’’ that includes a clear presentation of
guideline’s scope and purpose, stakeholder involvement, rigor
of development, clarity and presentation, applicability, and
editorial independence.23
In further phase, the feedback should be obtained from
members and practitioners regarding the guideline’s effective-
ness, and then the degree of guideline adherence and its clinical
impact should be evaluated. This further phase is strongly rec-
ommended for the present guideline to be implemented in the
future.
5. Conclusion and recommendations
In conclusion, the developed guideline is based on the needs of
the intended users (nurses) and end points beneﬁciaries (pa-
tients). Appraisers strongly recommended using this guideline
in the out-patients chest clinics.
164 A.I. Ahmed et al.The study recommended that the developed guideline
should be disseminated to the policy makers, to be applied in
the outpatients’ chest clinics and to be evaluated for its
achieved outcomes. Furthermore, supporting training pro-
grams would be established for nurses to fulﬁll the require-
ments of the guideline implementation and the expectation
of patients. These training programs will focus on the imple-
mentation plan of the guideline, nursing role in managing pul-
monary tuberculosis patient, principles of documentation and
communication skills.
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